help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miranda, A. F.
Right arrow Articles by Dimauro, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miranda, A. F.
Right arrow Articles by Dimauro, S.

American Journal of Pathology, Vol 132, 410-416, Copyright © 1988 by American Society for Investigative Pathology


REGULAR ARTICLES

Immunocytochemical study of dystrophin in muscle cultures from patients with Duchenne muscular dystrophy and unaffected control patients

AF Miranda, E Bonilla, G Martucci, CT Moraes, AP Hays and S Dimauro
Department of Pathology, Columbia University, New York, New York.

Using immunocytochemical methods, the localization of dystrophin, the gene product affected in Duchenne muscular dystrophy (DMD) in aneural, differentiating human muscle cultures, was studied. Dystrophin was not demonstrable in undifferentiated myoblasts from control patients and from two patients with DMD. After myoblast fusion, the protein was found in circumscribed sarcoplasmic patches, in the perinuclear area, and along the surface of all normal multinucleate myotubes, with more mature myotubes showing predominantly sarcolemmal distribution. There was no staining in myotubes from one DMD patient and only faint diffuse fluorescence in myotubes from the second affected boy, however. These data provide further evidence that dystrophin is a sarcolemma- associated protein, that it is developmentally regulated, and that it is absent or greatly reduced in quantity in skeletal muscle cultures from patients with DMD.


This article has been cited by other articles:


Home page
NEJMHome page
S. Sancho, T. Mongini, K. Tanji, S. J. Tapscott, W. F. Walker, H. Weintraub, A. D. Miller, and A. F. Miranda
Analysis of Dystrophin Expression after Activation of Myogenesis in Amniocytes, Chorionic-Villus Cells, and Fibroblasts -- A New Method for Diagnosing Duchenne's Muscular Dystrophy
N. Engl. J. Med., September 23, 1993; 329(13): 915 - 920.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
G. Dickson, A. Azad, G. E. Morris, H. Simon, M. Noursadeghi, and F. S. Walsh
Co-localization and molecular association of dystrophin with laminin at the surface of mouse and human myotubes
J. Cell Sci., December 1, 1992; 103(4): 1223 - 1233.
[Abstract] [PDF]


Home page
ScienceHome page
P. Fong, P. Turner, W. Denetclaw, and R. Steinhardt
Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin
Science, November 2, 1990; 250(4981): 673 - 676.
[Abstract] [PDF]


Home page
J Child NeurolHome page
J.A. Witkowski
Review Article: Dystrophin-Related Muscular Dystrophies
J Child Neurol, October 1, 1989; 4(4): 251 - 271.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Society for Investigative Pathology.